Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

To investigate the safety and efficacy of the moisturizing lotion in improving eczema symptoms among individuals with atopic eczema in Malaysia. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4.

The main questions this study aims to answer are:

1. To investigate the safety of the moisturizing lotion for individuals with atopic eczema in Malaysia.
2. To determine the efficacy of the moisturizing lotion in improving eczema lesions among individuals with atopic eczema in Malaysia.
3. To assess the participants' satisfaction after using the moisturizing lotion.

Inclusion Criteria:

• Healthy Malaysian women and men
• Age above 18 years old
• Clinically diagnosed with eczema with mild to moderate severity on any parts of the body as evaluated by Eczema Area and Severity Index (EASI) (score 10-20).

Exclusion Criteria:

• History of allergies or adverse reactions to moisturizers or components of the specific products being tested
• History of chronic allergies
• Pregnant, breastfeeding women, or those planning pregnancy during the study period
• Participants with documented autoimmune diseases.
• Currently undergoing or requiring active drug treatment for atopic dermatitis or eczema
• Use of any medication (topical or systemic) that could interfere with the study aim (e.g. corticosteroids, calcineurin inhibitors, methotrexate) 3 months prior to the start of the study treatment and throughout the study
• Current participation in another interventional clinical study
• Presence of dermatological or systemic disorder other than eczema that could interfere with study outcomes